About Us
Our Company
RemeGen Co., Ltd. (Yantai) was co-founded in 2008 by Mr. Wang Weidong, founder of Rongchang Pharmaceuticals, and Dr. Jianmin Fang a Canadian-American scientist. RemeGen is headquartered in Yantai, Shandong Province, China, with R&D centers and offices in China and the United States.
-
2A+H Dual-listed
-
8Clinical Pipelines
-
40 +Clinical Trials
-
600 +Patent Applications
RemeGen is committed to the discovery, development, production and commercialization of first-in-class and best-in-class biological drugs, and has developed a series of innovative biologics with significant clinical value for major diseases such as autoimmunity, oncology, and ophthalmology.
Our Vision
Remegen mission is to discover, develop, manufacture, and commercialize first-in-class and best-in-class biopharmaceuticals for major diseases such as autoimmune disorders, oncology, and ophthalmology, creating clinical value and satisfying significant unmet clinical needs globally, maximizing the value of the company. Our vision is to become a domestic leading and international first-class biopharmaceutical company.
Board of Directors
Executive Director
Non-Executive Director
Independent Non-Executive Director
林健先生，2008年7月至2019年6月担任公司董事长，2008年7月至2020年4月担任公司董事，2020 年 5 月至今担任公司执行董事，主要负责公司的整体管理、业务与战略规划。
林健先生于1982年获得黑龙江商学院（现称哈尔滨商业大学）中药制药专业工学学士学位。他在制药业有超过35年经验。
No. 58 Beijing Middle Road, Yantai Development Zone, Shandong, China.
（+86）535-3573511
Official WeChat